Lexicon Pharmaceuticals shares jumped nearly 75% in early trading Friday after the biopharmaceutical company inked a license agreement potentially worth $1 billion with Danish drug maker Novo Nordisk.

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ...

HengHong Technology, a holding company incorporated in the Cayman Islands, filed for a 2 million-share initial public offering, saying it intends to apply to list on the Nasdaq Capital Market under ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options ...

We are focused on leveraging our proprietary extraction technology ... and/or pharmaceuticals. The Company is listed on the Nasdaq Capital Market and the Toronto Stock Exchange, and trades on both ...

Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...

The new ticker symbol change is not only a brand identity ... We believe that with AI technology, our products and services will create an unparalleled intelligent experience for our users by ...

JCR Pharmaceuticals Co., Ltd., together with ... with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming ...

Digital asset payments will streamline transactions for dermatologists and plastic surgeons who dispense Young Pharmaceuticals' innovative skincare formulations and aesthetic technologies.